New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. New York released updated ...

DEA STYMIED MARIJUANA DRUG DEVELOPMENT - HOWEVER FDA MOVING FORWARD ON CANNABIS DRUG DEVELOPMENT FOR HUNTINGTON'S DISEASE "We ...

The state's recreational cannabis industry has expanded to be one of the biggest cannabis markets in the country. Here's what 2025 will look like.

Village Farms CEO Michael DeGiglio condemned the DEA's actions as an attempt to obstruct cannabis rescheduling, emphasizing their commitment to a transparent process and the health implications ...